Search

Author/Creator Marzocchi, Giulia

1. A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma. Issue 1 (1st November 2020)

Authors:
Rocchi, Serena; Tacchetti, Paola; Pantani, Lucia; Mancuso, Katia; Rizzello, Ilaria; di Giovanni Bezzi, Chiara; Scalese, Marco; Dozza, Luca; Marzocchi, Giulia; Martello, Marina; Barilà, Gregorio; Antonioli, Elisabetta; Staderini, Michela; Buda, Gabriele; Petrini, Mario; Cea, Michele; Quaresima, Mi...
Journal:
Hematological oncology
Issue:
Volume 39:Issue 1(2021)
Page Start:
41
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study. Issue 12 (December 2020)

Authors:
Tacchetti, Paola; Pantani, Lucia; Patriarca, Francesca; Petrucci, Maria Teresa; Zamagni, Elena; Dozza, Luca; Galli, Monica; Di Raimondo, Francesco; Crippa, Claudia; Boccadoro, Mario; Barbato, Simona; Tosi, Patrizia; Narni, Franco; Montefusco, Vittorio; Testoni, Nicoletta; Spadano, Antonio; Terrag...
Journal:
Lancet
Issue:
Volume 7:Issue 12(2020)
Page Start:
e861
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bortezomib‐based therapy combined with high cut‐off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment. Issue 7 (July 2015)

Authors:
Zannetti, Beatrice Anna; Zamagni, Elena; Santostefano, Marisa; De Sanctis, Lucia Barbara; Tacchetti, Paola; Mancini, Elena; Pantani, Lucia; Brioli, Annamaria; Rizzo, Raffaella; Mancuso, Katia; Rocchi, Serena; Pezzi, Annalisa; Borsi, Enrica; Terragna, Carolina; Marzocchi, Giulia; Santoro, Antonio;...
Journal:
American journal of hematology
Issue:
Volume 90:Issue 7(2015:Jul.)
Page Start:
647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities. Issue 4 (27th January 2016)

Authors:
Baldazzi, Carmen; Luatti, Simona; Zuffa, Elisa; Papayannidis, Cristina; Ottaviani, Emanuela; Marzocchi, Giulia; Ameli, Gaia; Bardi, Maria Antonella; Bonaldi, Laura; Paolini, Rossella; Gurrieri, Carmela; Rigolin, Gian Matteo; Cuneo, Antonio; Martinelli, Giovanni; Cavo, Michele; Testoni, Nicoletta
Journal:
Genes, chromosomes & cancer
Issue:
Volume 55:Issue 4(2016:Apr.)
Page Start:
375
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features. Issue 3 (22nd February 2016)

Authors:
Baldazzi, Carmen; Luatti, Simona; Paolini, Stefania; Papayannidis, Cristina; Marzocchi, Giulia; Ameli, Gaia; Martinelli, Giovanni; Cavo, Michele; Testoni, Nicoletta
Journal:
American journal of hematology
Issue:
Volume 91:Issue 3(2016:Mar.)
Page Start:
E14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens. Issue 9 (1st September 2016)

Authors:
Tacchetti, Paola; Cavo, Michele; Rocchi, Serena; Pezzi, Annalisa; Pantani, Lucia; Brioli, Annamaria; Testoni, Nicoletta; Terragna, Carolina; Zannetti, Beatrice Anna; Mancuso, Katia; Marzocchi, Giulia; Borsi, Enrica; Martello, Marina; Rizzello, Ilaria; Zamagni, Elena
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 9(2016:Sep.)
Page Start:
2058
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗